4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine-5'-O-monophosphate Sodium Salt

ID: ALA4084001

PubChem CID: 137646313

Max Phase: Preclinical

Molecular Formula: C14H15N3NaO7PS2

Molecular Weight: 433.40

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]

Standard InChI:  InChI=1S/C14H16N3O7PS2.Na/c1-26-13-8-11-6(2-3-27-11)17(12(8)15-5-16-13)14-10(19)9(18)7(24-14)4-23-25(20,21)22;/h2-3,5,7,9-10,14,18-19H,4H2,1H3,(H2,20,21,22);/q;+1/p-1/t7-,9-,10-,14-;/m1./s1

Standard InChI Key:  XYDBUVLKGXAXGU-WPPLYIOHSA-M

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   26.6027   -2.8130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6027   -3.6367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3125   -4.0494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.0264   -3.6340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0264   -2.8075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3098   -2.4005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3098   -1.5761    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   28.0194   -1.1607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8102   -2.5472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2990   -3.2156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8179   -3.8846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0782   -4.6661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6022   -5.3338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0888   -5.9983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8745   -5.7380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8745   -4.9138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5298   -4.4258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.5441   -6.2201    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.8394   -6.7846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0358   -6.9605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.7863   -7.7469    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   26.9785   -7.9226    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.3406   -8.3574    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.7863   -8.5685    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0795   -2.9585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0795   -2.1320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2926   -1.8784    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.5095   -9.1500    0.0000 Na  0  0  0  0  0 15  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  5  4  2  0
  5  6  1  0
  6  1  2  0
  6  7  1  0
  7  8  1  0
  9  5  1  0
  9 10  2  0
 11 10  1  0
  4 11  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16 17  1  6
 15 18  1  6
 14 19  1  1
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 21 24  1  0
 10 25  1  0
 25 26  2  0
 26 27  1  0
 27  9  1  0
M  CHG  2  24  -1  28   1
M  END

Associated Targets(Human)

ADK Tchem Adenosine kinase (1481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa S3 (477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.40Molecular Weight (Monoisotopic): 433.0167AlogP: 1.10#Rotatable Bonds: 5
Polar Surface Area: 147.16Molecular Species: ACIDHBA: 10HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 0.22CX Basic pKa: 5.13CX LogP: -2.11CX LogD: -2.57
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.26Np Likeness Score: 0.07

References

1. Tichý M, Smoleń S, Tloušt'ová E, Pohl R, Oždian T, Hejtmánková K, Lišková B, Gurská S, Džubák P, Hajdúch M, Hocek M..  (2017)  Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides.,  60  (6): [PMID:28221790] [10.1021/acs.jmedchem.6b01766]

Source